Posterior‐chamber phakic implantable collamer lenses with a central port: a review

We aimed to summarize the outcomes reported following the implantation of the V4c implantable collamer lens with a central port (ICL, STAAR Surgical Inc) for myopia correction. A literature search in PubMed, Web of Science and Scopus was carried out to identify publications reporting clinical outcom...

Full description

Saved in:
Bibliographic Details
Published inActa ophthalmologica (Oxford, England) Vol. 99; no. 3; pp. e288 - e301
Main Authors Montés‐Micó, Robert, Ruiz‐Mesa, Ramón, Rodríguez‐Prats, José Luís, Tañá‐Rivero, Pedro
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.05.2021
John Wiley and Sons Inc
Subjects
Adverse events
Cell density
Endothelial cells
Eye surgery
implantable collamer lens
intraocular pressure
Myopia
Patients
phakic
refraction
Review
Surgery
Surgical outcomes
vault
visual acuity
intraocular pressure
refraction
myopia
visual acuity
phakic
adverse events
implantable collamer lens
vault
Online AccessGet full text

Cover

More Information
Summary:We aimed to summarize the outcomes reported following the implantation of the V4c implantable collamer lens with a central port (ICL, STAAR Surgical Inc) for myopia correction. A literature search in PubMed, Web of Science and Scopus was carried out to identify publications reporting clinical outcomes of patients who were implanted with the V4c ICL model and had a follow‐up period of at least 6 months. A total of 35 clinical studies published between 2012 and 2020 were included in the present review. A comprehensive analysis of the available data was performed, focusing on visual and refractive outcomes at different time‐points post‐surgery. In addition, adverse events and other parameters such as endothelial cell density, intraocular pressure and vault measurements—which were evaluated in some of the studies—were also compared. This review encompassed a total of 2904 eyes. The outcomes reported in this review lead us to conclude that ICL V4c implantation for myopia correction is a safe and efficient procedure, with stable visual and refractive outcomes and low adverse event rates. The patient’s anterior segment should be thoroughly characterized, and the ICL parameters should be carefully selected so as to achieve good outcomes and avoid complications.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Robert Montés‐Micó declares research and consulting contracts with Alcon Laboratories, Essilor, Glaukos and STAAR Surgical through the University of Valencia.
ISSN:1755-375X
1755-3768
DOI:10.1111/aos.14599